Hari Manohar Medi Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 06-12-2024
- Paid Up Capital ₹ 2.46 M
as on 06-12-2024
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.70 Cr
as on 06-12-2024
- Revenue 9.42%
(FY 2022)
- Profit 530.16%
(FY 2022)
- Ebitda -1.74%
(FY 2022)
- Net Worth 23.95%
(FY 2022)
- Total Assets -18.44%
(FY 2022)
About Hari Manohar Medi Diagnostic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.46 M.
The company currently has active open charges totaling ₹8.70 Cr.
Preeti Bullagan and Ajay Bullagan serve as directors at the Company.
- CIN/LLPIN
U24233UP2008PTC035655
- Company No.
035655
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2008
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Hari Manohar Medi Diagnostic?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preeti Bullagan  | Director | 09-Jul-2008 | Current |
| Ajay Bullagan | Director | 09-Jul-2008 | Current |
Financial Performance of Hari Manohar Medi Diagnostic.
Hari Manohar Medi Diagnostic Private Limited., for the financial year ended 2022, experienced modest growth in revenue, with a 9.42% increase. The company also saw a substantial improvement in profitability, with a 530.16% increase in profit. The company's net worth Soared by an impressive increase of 23.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hari Manohar Medi Diagnostic?
In 2019, Hari Manohar Medi Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hari Krishan Diagnostic Private LimitedActive 14 years 11 monthsPreeti Bullagan and Ajay Bullagan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Jul 2018 | ₹7.00 M | Open |
Siemens Financial Services Private Limited Creation Date: 24 Jun 2015 | ₹5.50 Cr | Open |
Corporation Bank Creation Date: 17 Jan 2009 | ₹2.50 Cr | Open |
How Many Employees Work at Hari Manohar Medi Diagnostic?
Hari Manohar Medi Diagnostic has a workforce of 12 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hari Manohar Medi Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hari Manohar Medi Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
